Edwards Lifesciences (EW) PT Raised to $275 at Credit Suisse
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $91.04 -1.34%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Credit Suisse analyst Matt Miksic raised the price target on Edwards Lifesciences (NYSE: EW) to $275.00 (from $269.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Estee Lauder (EL) PT Raised to $112 at JPMorgan
- CrowdStrike (CRWD) PT Raised to $235 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
